Legal Body-Slimming Materil CAS168273-06-1 Rimonabant for Weight Loss

Legal Body-Slimming Materil CAS168273-06-1 Rimonabant for Weight Loss 

Product Name:Rimonabant
Synonyms:ACOMPLIA; RIMONABANT(ACOMPLIA,SR141716)
MF:C22H21Cl3N4O
MW:463.7873
CAS No.168273-06-1
Density1.41g/cm 3
Melting point:230 ~ 240 Centigrade 
Assay    99%min
Appearance:White or off-white crystalline powder
pH    (10% solution) 4-7 
Heavy metal    10ppm 
Loss on drying    ≤0.5% 
Package :1 kg foil bag 25 kg drum or as your requirement
Usage : Rimonabant is the generic name for Acomplia, which is an appetite suppressant 



Description
Rimonabant (also known as SR141716; trade names Acomplia, Zimulti) is an anorectic antiobesity drug that has been withdrawn from the market due to potentially serious side effects. It was approved for use in Europe and other countries, but never approved in the United States. Rimonabant is an inverse agonist for the cannabinoid receptor CB1. It has also been shown to be a μ-opioid receptor antagonist (possibly the contributing factor in its reported dysphoric qualities).Its main effect is reduction in appetite.
 

Applications
Rimonabant is an anorectic anti-obesity drug produced and marketed by Sanofi-Aventis. It is an inverse agonist for the cannabinoid receptor CB1. Its main avenue of effect is reduction in appetite. Rimonabant is the first selective CB1 receptor blocker to be approved for use anywhere in the world. Rimonabant is approved in 38 countries including the E.U., Mexico, and Brazil. It was rejected for approval for use in the United States. This decision was made after a U.S. advisory panel recommended the medicine not be approved because it may increase suicidal thinking and depression.
Rimonabant works by blocking endogenous cannabinoid from binding to neuronal CB1 receptors. The activation of these receptors by endogenous cannabinoids, such as anadamide, increases an individuals appetite. By blocking the activation of the receptors, appetite suppression may occur.

FAQ
Question 1 , How do you pack the order ?
Discreet package , the packing suits you best would be choosen to cross customs safely

Question 2 , What is your shipping method ?
Shipping by express (FedEx,UPS,DHL,EMS,HKEMS,TNT), and cheapest by airmail

Question 3 , if my order seized by custom ,what do you do ?
Resending police if the tracking number do not update online or it sezied by custom

Questions 4 , What is your payment accept ?
Safe and fast payment :Western Union ,Money Gram ,T/T ,Bitcoin

Questions 5 , Will you supply tracking number ?
Yes ,we supply tracking number for following .In general ,once we supply the tracking number to you ,you can track the parcel information within 1-2 business days

Question 6 , How many days will it take to my country after I do the payment ?
In general ,fastest with 3-5 business , slowest 5-7 business days


Hot selling market
United State(USA) , United Kingdom(UK) , Australia , Canada , Spain , France , Germany , Russia , Brasil(Brazil) , Ukraine , South Africa , Norway , Poland , Netherlands(Holland) , Slovakia , Georgia , New Zealand , Sweden etc.

 

 

 

 

Legal Body-Slimming Materil CAS168273-06-1 Rimonabant for Weight Loss 

Product Name:Rimonabant
Synonyms:ACOMPLIA; RIMONABANT(ACOMPLIA,SR141716)
MF:C22H21Cl3N4O
MW:463.7873
CAS No.168273-06-1
Density1.41g/cm 3
Melting point:230 ~ 240 Centigrade 
Assay    99%min
Appearance:White or off-white crystalline powder
pH    (10% solution) 4-7 
Heavy metal    10ppm 
Loss on drying    ≤0.5% 
Package :1 kg foil bag 25 kg drum or as your requirement
Usage : Rimonabant is the generic name for Acomplia, which is an appetite suppressant 



Description
Rimonabant (also known as SR141716; trade names Acomplia, Zimulti) is an anorectic antiobesity drug that has been withdrawn from the market due to potentially serious side effects. It was approved for use in Europe and other countries, but never approved in the United States. Rimonabant is an inverse agonist for the cannabinoid receptor CB1. It has also been shown to be a μ-opioid receptor antagonist (possibly the contributing factor in its reported dysphoric qualities).Its main effect is reduction in appetite.
 

Applications
Rimonabant is an anorectic anti-obesity drug produced and marketed by Sanofi-Aventis. It is an inverse agonist for the cannabinoid receptor CB1. Its main avenue of effect is reduction in appetite. Rimonabant is the first selective CB1 receptor blocker to be approved for use anywhere in the world. Rimonabant is approved in 38 countries including the E.U., Mexico, and Brazil. It was rejected for approval for use in the United States. This decision was made after a U.S. advisory panel recommended the medicine not be approved because it may increase suicidal thinking and depression.
Rimonabant works by blocking endogenous cannabinoid from binding to neuronal CB1 receptors. The activation of these receptors by endogenous cannabinoids, such as anadamide, increases an individuals appetite. By blocking the activation of the receptors, appetite suppression may occur.

FAQ
Question 1 , How do you pack the order ?
Discreet package , the packing suits you best would be choosen to cross customs safely

Question 2 , What is your shipping method ?
Shipping by express (FedEx,UPS,DHL,EMS,HKEMS,TNT), and cheapest by airmail

Question 3 , if my order seized by custom ,what do you do ?
Resending police if the tracking number do not update online or it sezied by custom

Questions 4 , What is your payment accept ?
Safe and fast payment :Western Union ,Money Gram ,T/T ,Bitcoin

Questions 5 , Will you supply tracking number ?
Yes ,we supply tracking number for following .In general ,once we supply the tracking number to you ,you can track the parcel information within 1-2 business days

Question 6 , How many days will it take to my country after I do the payment ?
In general ,fastest with 3-5 business , slowest 5-7 business days


Hot selling market
United State(USA) , United Kingdom(UK) , Australia , Canada , Spain , France , Germany , Russia , Brasil(Brazil) , Ukraine , South Africa , Norway , Poland , Netherlands(Holland) , Slovakia , Georgia , New Zealand , Sweden etc.